Jonathan Javitt
2023
In 2023, Jonathan Javitt earned a total compensation of $630.2K as Chairman and Chief Scientist at NRX Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Salary | $602,755 |
|---|---|
| Other | $27,443 |
| Total | $630,198 |
Javitt received $602.8K in salary, accounting for 96% of the total pay in 2023.
Javitt also received $27.4K in other compensation.
Rankings
In 2023, Jonathan Javitt's compensation ranked 1,752nd out of 2,983 executives tracked by ExecPay. In other words, Javitt earned more than 41.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,752 out of 2,983 | 41st |
Division Manufacturing | 1,016 out of 1,637 | 38th |
Major group Chemicals And Allied Products | 639 out of 906 | 30th |
Industry group Drugs | 623 out of 869 | 28th |
Industry Pharmaceutical Preparations | 446 out of 627 | 29th |
Source: SEC filing on September 5, 2024.
Javitt's colleagues
We found two more compensation records of executives who worked with Jonathan Javitt at NRX Pharmaceuticals in 2023.